AVITA MEDICAL CDI 5:1 (AVH) Short Interest
AVITA MEDICAL CDI 5:1 (ASX:AVH) had 0.41% of shares reported as short positions as of 26 June 2026, representing 347,642 shares. AVITA MEDICAL CDI 5:1 operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
AVH
Avita Medical Inc.
Avita Medical Inc. is a regenerative medicine company specializing in therapeutic skin restoration. Their flagship product, the RECELL System, is FDA-approved for treating thermal burn wounds and full-thickness skin defects. The company leverages patient-derived skin cells to enhance healing and accelerate recovery, positioning itself as a leader in acute wound care solutions.